Evidence map›Paper›PMID 34511982›Full record

ArticleInternational journal of general medicine2021

Laboratory and Imaging Evaluation of Cardiac Involvement in Patients with Post-Acute COVID-19.

Ersin Sarıçam, Ali Doğan Dursun, Gülçin Türkmen Sarıyıldız, Nalan Can, Engin Bozkurt, Uğur Gönüllü, Nihal Basay, Meral Türkmen, Abdülaziz Denli, Mustafa Ünlü

Open access · goldAbstract read
In one paragraph

Article in International journal of general medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 4 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 4 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Trial
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Nuclear Cardiology in the COVID-19 pandemic.Revista espanola de medicina nuclear e imagen molecular
    Article
  17. [Nuclear Cardiology in the COVID-19 pandemic].Revista espanola de medicina nuclear e imagen molecular
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Ersin SarıçamDepartment of Cardiology, Medicana International Ankara Hospital, Ankara, Turkey.ORCID 0000-0002-8736-1786
Ali Doğan DursunDepartment of Physiology, Atılım University Medical School, Ankara, Turkey.ORCID 0000-0001-9056-0025
Gülçin Türkmen SarıyıldızDepartment of General Surgery, Medicana International Ankara Hospital, Ankara, Turkey.
Nalan CanDepartment of Nuclear Medicine, Medicana International Ankara Hospital, Ankara, Turkey.
Engin BozkurtDepartment of Cardiology, Medicana International Ankara Hospital, Ankara, Turkey.
Uğur GönüllüDepartment of Pulmonary Medicine, Atılım University Medical School, Ankara, Turkey.
Nihal BasayDepartment of Pulmonary Medicine, Medicana International Ankara Hospital, Ankara, Turkey.
Meral TürkmenDepartment of Internal Medicine, Medicana International Ankara Hospital, Ankara, Turkey.
Abdülaziz DenliDepartment of Physical Medicine and Rehabilitation, Medicana International Ankara Hospital, Ankara, Turkey.
Mustafa ÜnlüDepartment of Nuclear Medicine, Gazi University Medical School, Ankara, Turkey.
Memorial Ankara Hospital · TRAnkara University · TRGazi University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the post-acute COVID-19 syndrome, many patients suffer from palpitations, effort-associated fatigue, and even sudden death. The mechanism of heart involvement in this syndrome is uncertain. The main purpose of the study was to identify possible cardiac involvement causes in patients with post-acute COVID-19 by using biomarkers such as NT-proBNP and nitric oxide (NO) and cardiac imaging modalities.

methodsIn this cross-sectional study, a total of 105 participants were included according to the existence of symptoms, and 40 of these participants were asymptomatic patients. The ages of the participants ranged from 20 to 50 years. All patients were healthy before COVID-19. The symptoms were defined as palpitations and/or fatigue association with exercise in post-acute COVID-19 term. The comparison of the two groups was made by using biochemical parameters (NT-proBNP, Troponin I, NO) and imaging techniques (echocardiography, cardiovascular magnetic resonance (CMR) and cardiac positron emission tomography (PET)).

resultsThe symptomatic patients had higher NT-proBNP levels compared with asymptomatic patients (132.30±35.15; 76.86±16.79, respectively; p < 0.001). Interestingly, the symptomatic patients had lower NO levels than asymptomatic patients (9.20±3.08; 16.15±6.02, respectively; p < 0.001). Echocardiography and CMR were normal. However, we found regional increased 18F-FDG uptake on cardiac PET to be compatible with myocardial fatigue.

conclusionWe found elevated NT-proNBP levels, low serum NO levels, and increased 18F-FDG uptake on cardiac PET in post-acute COVID syndrome. Cardiac PET could replace or be added to CMR for detecting subtle subacute/chronic myocarditis. The follow-up of patients with post-acute COVID-19 could target the possibility of risk of heart failure.

Indexed as

cardiac involvementimaginglaboratory testspost-acute COVID-19

Identifiers

PMID34511982
PMCPMC8412825
OpenAlexW3198828384

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.